the cost-effectiveness of targeted therapies in nsclc
Published 11 years ago • 266 plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
21:36
costs and cost efficacy of managing nsclc in the new millennia
-
1:03:21
incorporating ngs in an asian non-small cell lung cancer (nsclc) population -a cost-effectiveness...
-
2:16
the cost of targeted therapy - 2022 program: lcvl
-
3:31
cost effectiveness of frontline therapies for metastatic pancreatic cancer
-
7:44
next-generation targeted therapies in non-small cell lung cancer
-
3:04
final thoughts on targeted therapy and i/o agents in nsclc
-
2:12
dr. pennell on the evolution of targeted treatment in nsclc
-
4:38
targeted therapy in nsclc
-
1:31
dr. papadimitrakopoulou on importance of more targeted therapies in nsclc
-
5:10
sequencing egfr-targeted therapies in nsclc
-
1:18
dr. lopategui on the evolution of targeted therapies in nsclc
-
4:08
targeted therapies in lung cancer
-
1:45
dr. feliciano on ros1-targeted therapy in nsclc
-
5:29
development of kras g12c-targeted therapy in nsclc
-
2:00
cost-effectiveness of mm treatment
-
4:05
the evolution of alk/ros1-targeted therapy in nsclc
-
1:00
dr. villaruz on egfr-targeted therapies in nsclc
-
4:41
upfront egfr-targeted therapy for nsclc
-
3:41
targeted therapy versus standards of care in metastatic nsclc